Vimarsana
Biggest News Aggregation in the World

Severe Hypertriglyceridemia News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Severe Hypertriglyceridemia. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Severe Hypertriglyceridemia Today - Breaking & Trending Today

Cholesterol Medicines Guide - Vimarsana News

Cholesterol Medicines Guide

This guide lists FDA-approved products currently available to treat high cholesterol levels and discusses the current approach to treating high cholesterol.

Source: fda.gov
Amarin Partner EddingPharm Receives Regulatory Approval for Vascepa® (Icosapent Ethyl) in Mainland China - Vimarsana News

Amarin Partner EddingPharm Receives Regulatory Approval for Vascepa® (Icosapent Ethyl) in Mainland China

-- VASCEPA Approved by the National Medical Products Administration as an Adjunct to Diet to Reduce Triglyceride Levels in Adult Patients with Severe Hypertriglyceridemia -- -- EddingPharm Now... | June 1, 2023

Amarin Corporation plc: Amarin Partner EddingPharm Receives Regulatory Approval for Vascepa® (Icosapent Ethyl) in Mainland China - Vimarsana News

Amarin Corporation plc: Amarin Partner EddingPharm Receives Regulatory Approval for Vascepa® (Icosapent Ethyl) in Mainland China

-- VASCEPA Approved by the National Medical Products Administration (NMPA) as an Adjunct to Diet to Reduce Triglyceride Levels in Adult Patients with Severe Hypertriglyceridemia (= 500 mg/dL) -- --

NorthSea Therapeutics Appoints Morris J. Birnbaum to the Board - Vimarsana News

NorthSea Therapeutics Appoints Morris J. Birnbaum to the Board

Former Pfizer Internal Medicine CSO joins the Board as an independent board member NorthSea Therapeutics B.V. ('NST'), a biotech company developing novel and innovative strategies for the treatment

DelveInsight Business Research, LLP: The Severe Hypertriglyceridemia Market is Expected to Increase with a CAGR of 8.1% During the Study Period (2019-32) - Vimarsana News

DelveInsight Business Research, LLP: The Severe Hypertriglyceridemia Market is Expected to Increase with a CAGR of 8.1% During the Study Period (2019-32)

The overall Severe Hypertriglyceridemia market is expected to increase due to the rising prevalent cases over the globe and thus the surge in treatment options. In addition, the expected launch